Aspex Management (HK)’s New Frontier Health Corporation Ordinary Shares NFH Stock Holding History

Aspex Management (HK)’s Portfolio NFH Stock Details NFH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,081,250	Closed	-$46.8M	–	32
2021 Q4	$46.8M	Hold	4,081,250	–	–	1.43%	17
2021 Q3	$45.8M	Hold	4,081,250	–	–	1.53%	17
2021 Q2	$45.6M	Hold	4,081,250	–	–	1.49%	16
2021 Q1	$46.1M	Hold	4,081,250	–	–	1.83%	15
2020 Q4	$35.1M	Hold	4,081,250	–	–	1.38%	18
2020 Q3	$31.1M	Hold	4,081,250	–	–	2%	12
2020 Q2	$33.8M	Hold	4,081,250	–	–	4.15%	8
2020 Q1	$33.7M	Buy	4,081,250 +1,350,000	+49%	+$12.3M	4.66%	8
2019 Q4	$27.3M	Buy	+2,731,250	New	+$27.9M	4.97%	9

Other funds holding NFH

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Aspex Management (HK)'s NFH Position: Q1 2022 in Review

Aspex Management (HK) sold out of New Frontier Health Corporation Ordinary Shares (NFH) in Q1 2022, closing a stake of 4,081,250 shares — an estimated $46.8M sold.

Aspex Management (HK) first reported a position in NFH in Q4 2019 and held it in 9 quarters. The position peaked at $46.8M in Q4 2021. 2 funds tracked by Wall St. Rank hold NFH as of Q1 2022.

Aspex Management (HK) reported no remaining New Frontier Health Corporation Ordinary Shares position as of Q1 2022 after selling out during the quarter.
Aspex Management (HK) sold 4,081,250 New Frontier Health Corporation Ordinary Shares shares in Q1 2022, an estimated $46.8M.
Aspex Management (HK) first reported a position in New Frontier Health Corporation Ordinary Shares in Q4 2019 and held it in 9 quarters.
Aspex Management (HK)'s New Frontier Health Corporation Ordinary Shares position peaked at $46.8M in Q4 2021.
2 funds tracked by Wall St. Rank held New Frontier Health Corporation Ordinary Shares as of Q1 2022.

Based on Aspex Management (HK)'s 13F filing for Q1 2022, filed 9 May 2022.